Leveraging NAMs to understand disease triggers, discover early biomarkers and develop new classes of therapeutic strategies for Type 1 Diabetes (U01 Clinical Trial Not Allowed)
Status: Forecast, not open yet
- Who can apply
- Nonprofits, small businesses, state, local and tribal governments, tribes, schools and universities, for-profit companies, others.
- Deadline
- Expected around Feb 10, 2027 (forecast, not confirmed)
- Opened Nov 5, 2026
- Amount
- $12M total available
- Expected awards: 12
- Official source
- Read and apply at the official source Found on grants.gov
- Requirements
- See the official notice
- Organizations need a SAM.gov ID number (UEI) to apply. Individuals do not.
- Application fee
- We do not read fees from notices; check the official notice. GrantsWindow never charges you.
- Funder
- National Institutes of Health (federal)
- Assistance Listing 93.855, 93.KRP
- Last checked
- Checked Nov 15, 2026 at the official source
From the official notice
This NOFO will support research using human-relevant New Approach Methodologies (NAMs) to advance understanding of the earliest events that initiate and drive Type 1 Diabetes (T1D). Projects will use human cells and tissues and innovative experimental and computational approaches–including ...
Topics this may fit (our guess)
minority-serving